16 October 2014 - The Union Cycliste Internationale (UCI) will ask the Licence Commission to undertake a full review of the management and anti-doping policies of the Astana Pro Team.
This follows the serious concerns raised by the fact that two Astana riders Maxim and Valentin Iglinskiy recently tested positive for EPO and the notification this week that llya Davidenok has returned an Adverse Analytical Finding for anabolic androgenic steroids in a sample collected at the Tour de l’Avenir on 28th August 2014. IIya Davidenok has ridden from 1st January 2012 to date for Continental Team Astana and since 1st August 2014 has also been a stagiaire with Astana Pro Team. The rider has the right to request analysis of the B sample and in accordance with UCI Anti-doping Rules has been provisionally suspended until the adjudication of the matter. At this stage of the procedure, the UCI will not comment any further on this individual case.
The Licence Commission is the competent body for issuing, reviewing, withdrawing and attaching conditions to UCI WorldTour licences and ensuring that licence-holders continuously comply with the terms of the licence. As per the UCI Regulations, it is expected that the team will appear before the Licence Commission within the next month for an assessment of the team’s level of compliance with the ethical criteria so that the appropriate measures can be then taken. It will be for the Licence Commission to determine whether and to what extent the team and/or its management is responsible for recent events. The UCI will not comment further at this stage.
For more information:
UCI Press Officer
+41 79 198 7047
+44 7813 814 816